◼ Archived
Business
🔮 fades ✓
US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment
The US FDA has approved Lantheus and Enigma Biomedical's brain-imaging agent Tauklarify for Alzheimer's disease assessment.